Martin W. Elmlinger

3.1k citations

62 papers · 2.5k indexed · h-index 30

Endocrinology, Diabetes and Metabolism top 1%
Molecular Biology top 10%
Pulmonary and Respiratory Medicine top 10%
Pediatrics, Perinatology and Child Health top 5%
Genetics top 10%

Co-authors: Michael B. Ranke Werner Kühnel Matthias M. Weber Hans Mohr Roland Schweizer Andreas Hoeflich Patricia M. Crofton C.J.H. Kelnar
Topics: Growth Hormone and Insulin-like Growth Factors (31 papers)Hormonal and reproductive studies (8 papers)Lipid metabolism and disorders (8 papers)
Cited by: Endocrinology, Diabetes and Metabolism Pediatrics, Perinatology and Child Health Reproductive Medicine
Journals: Journal of Biological Chemistry PLoS ONE The Journal of Clinical Endocrinology & Metabolism
Partner nations: Germany United States United Kingdom

In The Last Decade

Martin W. Elmlinger

62 papers receiving 2.4k citations

Peers

Countries citing papers authored by Martin W. Elmlinger

Since Specialization

Citations

This map shows the geographic impact of Martin W. Elmlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin W. Elmlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin W. Elmlinger more than expected).

Fields of papers citing papers by Martin W. Elmlinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin W. Elmlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin W. Elmlinger. The network helps show where Martin W. Elmlinger may publish in the future.

Co-authorship network of co-authors of Martin W. Elmlinger

This figure shows the co-authorship network connecting the top 25 collaborators of Martin W. Elmlinger. A scholar is included among the top collaborators of Martin W. Elmlinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin W. Elmlinger. Martin W. Elmlinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum 2012 ·PLoS ONE ·(unknown),Olaf Holz,Gereon Lauer,Meike Müller,Susanne Rittinghausen,Peter B. Ernst,Gëzim Lahu,Martin W. Elmlinger,Norbert Krug,Jens M. Hohlfeld	58
2	Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD 2011 ·Respiratory Research ·Carla Winkler,Elena N. Atochina‐Vasserman,Olaf Holz,Michael F. Beers,Veit J. Erpenbeck,Norbert Krug,Stefan Roepcke,Gereon Lauer,Martin W. Elmlinger,Jens M. Hohlfeld	103
3	Neuroprotective and Anti-Oxidative Effects of the Hemodialysate Actovegin on Primary Rat Neurons in Vitro 2011 ·NeuroMolecular Medicine ·Martin W. Elmlinger,Martin Kriebel,Dan Ziegler	43
4	Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide 2010 ·The Journal of Clinical Pharmacology ·Gëzim Lahu,Nassr Nassr,Rolf Herzog,Martin W. Elmlinger,Peter Ruth,Markus Hinder,(unknown)	18
5	Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide 2009 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown),(unknown),Rolf Herzog,Nigel McCracken,Róbert Hermann,Martin W. Elmlinger,Karl Zech	24
6	IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment. 2006 ·Journal of Carcinogenesis ·Daniela Diehl,Doris Oesterle,Martin W. Elmlinger,Andreas Hoeflich,Eckhard Wolf,Harald Lahm	13
7	Tissue-Specific Effects of In Vitro Fertilization Procedures on Genomic Cytosine Methylation Levels in Overgrown and Normal Sized Bovine Fetuses1 2006 ·Biology of Reproduction ·Stefan Hiendleder,(unknown),Cora Mund,Martina Klempt,Horst-Dieter Reichenbach,Miodrag Stojković,Myriam Weppert,Hendrik Wenigerkind,Martin W. Elmlinger,Frank Lyko,Oliver J. Schmitz,Eckhard Wolf	54
8	Transgenic Mice Reveal Novel Activities of Growth Hormone in Wound Repair, Angiogenesis, and Myofibroblast Differentiation 2004 ·Journal of Biological Chemistry ·Irmgard S. Thorey,Boris Hinz,Andreas Hoeflich,Susanne Kaesler,Philippe Bugnon,Martin W. Elmlinger,Rüdiger Wanke,Eckhard Wolf,Sabine Werner	40
9	Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo 2004 ·Biochemical and Biophysical Research Communications ·Andreas Hoeflich,(unknown),Burkhardt S. Schüett,Martin W. Elmlinger,Vincenzo Russo,(unknown),P. M. Jehle,Harald Lahm,Ingrid Renner‐Müller,Eckhard Wolf	29
10	Reference Levels of Insulin-Like Growth Factor I in the Serum of Healthy Adults: Comparison of Four Immunoassays 2003 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Michael B. Ranke,Karl Josef Osterziel,Roland Schweizer,Burkhardt S. Schüett,Karin Weber,(unknown),(unknown),Gunnar Blumenstock,Martin W. Elmlinger	32
11	Comparison of inflammatory and systemic sources of growth factors in acute and chronic human wounds 2003 ·Wound Repair and Regeneration ·Silvia Wagner,S. Coerper,Jens Fricke,Thomas K. Hunt,(unknown),Martin W. Elmlinger,(unknown),Horst D. Becker	30
12	Hypoglykämien bei malignem Hämangioperizytom der Leber 2003 ·DMW - Deutsche Medizinische Wochenschrift ·(unknown),Albrecht Reichle,Martin W. Elmlinger,J Schölmerich	4
13	Insulin‐like growth factor binding protein 2 (IGFBP‐2) separates hypertrophic and hyperplastic effects of growth hormone (GH)/IGF‐I excess on adrenocortical cells in vivo 2002 ·The FASEB Journal ·Andreas Hoeflich,Matthias M. Weber,(unknown),Sabine Nedbal,Christian Fottner,Martin W. Elmlinger,Rüdiger Wanke,Eckhard Wolf	42
14	Mutation of the RGD sequence does not affect plasma membrane association and growth inhibitory effects of elevated IGFBP‐2 in vivo 2002 ·FEBS Letters ·Andreas Hoeflich,(unknown),(unknown),Martin W. Elmlinger,Burkhardt S. Schüett,P. M. Jehle,Ingrid Renner‐Müller,Harald Lahm,Vincenzo Russo,Eckhard Wolf	29
15	Decreased Expression of IGF-II and Its Binding Protein, IGF-Binding Protein-2, in Genital Skin Fibroblasts of Patients with Complete Androgen Insensitivity Syndrome Compared with Normally Virilized Males 2001 ·The Journal of Clinical Endocrinology & Metabolism ·Martin W. Elmlinger	2
16	Relevance of IGF-I, IGFBP-3, and IGFBP-2 Measurements during GH Treatment of GH-Deficient and Non-GH-Deficient Children and Adolescents 2001 ·Hormone Research in Paediatrics ·Michael B. Ranke,Roland Schweizer,Martin W. Elmlinger,Karin Weber,Gerhard Binder,C. P. Schwarze,H Wollmann	61
17	Correlation of type I insulin-like growth factor receptor (IGF-I-R) and insulin receptor-related receptor (IRR) messenger RNA levels in tumor cell lines from pediatric tumors of neuronal origin 1999 ·Regulatory Peptides ·Martin W. Elmlinger,(unknown),Ewa Kościelniak,(unknown),Michael B. Ranke,A. Berthold,Jürgen Klammt,Wieland Kieß	7
18	Activation‐dependent expression of the insulin‐like growth factor binding protein‐2 in human lymphocytes 1998 ·Immunology ·Jürgen Föll,(unknown),(unknown),Simone Hettmer,N. Berger,Martin W. Elmlinger,D Niethammer,Michael B. Ranke,Guenther E. Dannecker	12
19	Glutamine synthetase in Scots pine seedlings and its control by blue light and light absorbed by phytochrome 1992 ·Planta ·Martin W. Elmlinger,Hans Mohr	28
20	Coaction of blue/ultraviolet-A light and light absorbed by phytochrome in controlling the appearance of ferredoxin-dependent glutamate synthase in the Scots pine (Pinus sylvestris L.) seedling 1991 ·Planta ·Martin W. Elmlinger,Hans Mohr	29

About Martin W. Elmlinger

Martin W. Elmlinger is a scholar working on Endocrinology, Diabetes and Metabolism, Neurology and Occupational Therapy, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (31 papers), Hormonal and reproductive studies (8 papers) and Lipid metabolism and disorders (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Pediatrics, Perinatology and Child Health (339 citations) and Reproductive Medicine (129 citations). Martin W. Elmlinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael B. Ranke, Werner Kühnel, Matthias M. Weber, Hans Mohr, Roland Schweizer, Andreas Hoeflich, Patricia M. Crofton, C.J.H. Kelnar, Karin Weber and Eckhard Wolf. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact